March 14, 2024 | By Michelle Jones | Clinical Research, Clinical Trials, Liver, Liver Disease, Liver Health, NASH, News & Events
Today, we’re talking about some exciting news for people battling fatty liver disease, specifically Nonalcoholic Steatohepatitis (NASH) a condition where too much fat is stored in the liver, causing inflammation and damage. NASH is a tricky disease because it’s often …
March 14, 2024 | By Michelle Jones | News & Events, Clinical Trials, Liver, Liver Disease, Liver Health, NASH | Promising Advance in Treatment, resmetirom, Rezdiffra
Nonalcoholic Steatohepatitis (NASH) (now known as Metabolic Dysfunction-Associated Steatohepatitis or MASH) represents a significant and growing challenge in clinical practice, with its progression to cirrhosis and hepatocellular carcinoma posing serious risks for patients. The exciting new conditional commercial launch of …
June 15, 2023 | By John Raslavsky | Cirrhosis, Clinical Trials, Liver Disease, Liver Health, Volunteering in Research | Cirrhosis, Clinical research, Clinical trials, Fatty Liver Disease, liver health, Liver research, Liver Scarring
Liver cirrhosis is a chronic and potentially life-threatening condition affecting many worldwide and in Arizona. Historically, men have been disproportionately affected by liver cirrhosis. Studies show that death rates amongst men with liver cirrhosis are twice as high as women. …
May 19, 2023 | By John Raslavsky | Liver, Liver Disease | Alcohol-related Liver Disease, Fibroscan, liver health, Women's Liver Health
May is Women’s Health Awareness Month, and it’s more important than ever to address the alarming rise of alcohol-related liver disease in young women. Let’s work together to empower women to make informed decisions regarding their liver health. Read our …
April 13, 2023 | By John Raslavsky | Liver, Liver Disease | Blog, Clinical research, CT Scan, Fatty Liver Disease, Fibroscan, liver health, MRI
Have you ever wondered how well your liver is functioning? Our latest blog gives you the inside scoop on the 3 most common liver scans. Learn more about what they are, how they work, and who can benefit from them! …
February 24, 2023 | By John Raslavsky | Liver, NASH | Blog, Clinical trials, Fatty Liver Disease, Fibroscan, Liver disease, liver health
Obesity has become one of the most common and serious public health issues in recent years, leading to many health problems. Yet, many remain unaware of the consequences of obesity on the liver. Learn more in our blog below! Excess …
January 9, 2023 | By John Raslavsky | Liver, Liver Health | 2023, Arizona, Blog, Clinical research, Liver awareness, Liver research, New year new liver health
The new year is here, and the promise of more liver research comes with it. The more we understand the liver, the better we can treat its issues. From participating in clinical trials to simply raising awareness, there’s something everyone …
December 23, 2022 | By John Raslavsky | Liver, Liver Disease, Liver Health
The holiday season is finally upon us, which means it’s time for yummy foods and tasty alcoholic beverages. Many go into this season with a stress-free attitude over the food and drinks they consume. However, they aren’t considering the …
December 9, 2022 | By John Raslavsky | Effects of HIV on the Liver, Liver | AIDS, Blog, Clinical research, Fatty Liver Disease, Fibroscan, HIV, Liver disease, liver health
December is National HIV/AIDS Awareness Month, and many people are unaware of the significant impact this virus can have on the liver. HIV is one of the leading causes of cirrhosis and NASH in the United States. Let’s take a …
November 4, 2022 | By John Raslavsky | Diabetes, Liver | Blog, Clinical research, Fatty Liver Disease, Fibroscan, liver health, NAFLD
November is National Diabetes Month. What better time to discuss one of the lesser-known effects of diabetes, its impact on the liver? Diabetes can result in a range of liver conditions, some of which can be serious. In this blog …